Update on chemonucleolysis

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

A review of the world medical literature on chemonucleolysis with an emphasis on recent studies, meta-analyses, and the history of the procedure in North America from a regulatory, social, and medicolegal perspective was performed to determine the current status of chemonucleolysis in the management of disc displacement. The world literature supports the use of chymopapain for chemonucleolysis as a safe and effective alternative to surgical disc excision. The efficacy of chymopapain has been shown by prospective, randomized, placebo-controlled, double-blind trials with a minimum 10-year follow-up period. The safety of chymopapain injection compared with surgery has been demonstrated in mete-analyses and in extensive post-marketing surveillance in the United States and Europe. Clinical studies with collagenase and laboratory studies with chondroitinase ABC have shown that chemonucleolysis can be performed with enzymes other than chymopapain. Clinical trials have been performed with collagenase for chemonucleolysis, but all of the results have not been published. Preclinical research with chondroitinase ABC has demonstrated its usefulness for chemonucleolysis in the animal model, but human trials have not begun.

Original languageEnglish
JournalSpine
Volume21
Issue number24 SUPPL.
StatePublished - Dec 15 1996

Fingerprint

Intervertebral Disc Chemolysis
Chymopapain
Chondroitin ABC Lyase
Collagenases
North America
Marketing
Meta-Analysis
Animal Models
History
Placebos
Clinical Trials
Safety
Injections
Enzymes
Research

Keywords

  • chemonucleolysis
  • chondroitinase
  • chymopapain
  • collagenase

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Orthopedics and Sports Medicine

Cite this

Brown, M. (1996). Update on chemonucleolysis. Spine, 21(24 SUPPL.).

Update on chemonucleolysis. / Brown, Mark.

In: Spine, Vol. 21, No. 24 SUPPL., 15.12.1996.

Research output: Contribution to journalArticle

Brown, M 1996, 'Update on chemonucleolysis', Spine, vol. 21, no. 24 SUPPL..
Brown M. Update on chemonucleolysis. Spine. 1996 Dec 15;21(24 SUPPL.).
Brown, Mark. / Update on chemonucleolysis. In: Spine. 1996 ; Vol. 21, No. 24 SUPPL.
@article{1ac7190f485744ae910f45eb949777bf,
title = "Update on chemonucleolysis",
abstract = "A review of the world medical literature on chemonucleolysis with an emphasis on recent studies, meta-analyses, and the history of the procedure in North America from a regulatory, social, and medicolegal perspective was performed to determine the current status of chemonucleolysis in the management of disc displacement. The world literature supports the use of chymopapain for chemonucleolysis as a safe and effective alternative to surgical disc excision. The efficacy of chymopapain has been shown by prospective, randomized, placebo-controlled, double-blind trials with a minimum 10-year follow-up period. The safety of chymopapain injection compared with surgery has been demonstrated in mete-analyses and in extensive post-marketing surveillance in the United States and Europe. Clinical studies with collagenase and laboratory studies with chondroitinase ABC have shown that chemonucleolysis can be performed with enzymes other than chymopapain. Clinical trials have been performed with collagenase for chemonucleolysis, but all of the results have not been published. Preclinical research with chondroitinase ABC has demonstrated its usefulness for chemonucleolysis in the animal model, but human trials have not begun.",
keywords = "chemonucleolysis, chondroitinase, chymopapain, collagenase",
author = "Mark Brown",
year = "1996",
month = "12",
day = "15",
language = "English",
volume = "21",
journal = "Spine",
issn = "0362-2436",
publisher = "Lippincott Williams and Wilkins",
number = "24 SUPPL.",

}

TY - JOUR

T1 - Update on chemonucleolysis

AU - Brown, Mark

PY - 1996/12/15

Y1 - 1996/12/15

N2 - A review of the world medical literature on chemonucleolysis with an emphasis on recent studies, meta-analyses, and the history of the procedure in North America from a regulatory, social, and medicolegal perspective was performed to determine the current status of chemonucleolysis in the management of disc displacement. The world literature supports the use of chymopapain for chemonucleolysis as a safe and effective alternative to surgical disc excision. The efficacy of chymopapain has been shown by prospective, randomized, placebo-controlled, double-blind trials with a minimum 10-year follow-up period. The safety of chymopapain injection compared with surgery has been demonstrated in mete-analyses and in extensive post-marketing surveillance in the United States and Europe. Clinical studies with collagenase and laboratory studies with chondroitinase ABC have shown that chemonucleolysis can be performed with enzymes other than chymopapain. Clinical trials have been performed with collagenase for chemonucleolysis, but all of the results have not been published. Preclinical research with chondroitinase ABC has demonstrated its usefulness for chemonucleolysis in the animal model, but human trials have not begun.

AB - A review of the world medical literature on chemonucleolysis with an emphasis on recent studies, meta-analyses, and the history of the procedure in North America from a regulatory, social, and medicolegal perspective was performed to determine the current status of chemonucleolysis in the management of disc displacement. The world literature supports the use of chymopapain for chemonucleolysis as a safe and effective alternative to surgical disc excision. The efficacy of chymopapain has been shown by prospective, randomized, placebo-controlled, double-blind trials with a minimum 10-year follow-up period. The safety of chymopapain injection compared with surgery has been demonstrated in mete-analyses and in extensive post-marketing surveillance in the United States and Europe. Clinical studies with collagenase and laboratory studies with chondroitinase ABC have shown that chemonucleolysis can be performed with enzymes other than chymopapain. Clinical trials have been performed with collagenase for chemonucleolysis, but all of the results have not been published. Preclinical research with chondroitinase ABC has demonstrated its usefulness for chemonucleolysis in the animal model, but human trials have not begun.

KW - chemonucleolysis

KW - chondroitinase

KW - chymopapain

KW - collagenase

UR - http://www.scopus.com/inward/record.url?scp=0030460695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030460695&partnerID=8YFLogxK

M3 - Article

C2 - 9112326

AN - SCOPUS:0030460695

VL - 21

JO - Spine

JF - Spine

SN - 0362-2436

IS - 24 SUPPL.

ER -